Navigation Links
K-V Pharmaceutical Secures Financing Commitments Establishing Path Forward For Specialty Pharmaceutical Business
Date:11/17/2010

ant, the "Warrants").  All warrants issued will have an exercise price of $1.62 per share.  Jefferies & Co advised the Company on the above transaction.  

Board Appoints Experienced Veteran to CEO Post

The Board of Directors also announced today that it has appointed Greg Divis as the permanent Chief Executive Officer of the Company.  Mr. Divis has served as the Company's Interim CEO since June 10, 2010, and will continue to serve as President of Ther-Rx Corporation, the branded pharmaceutical subsidiary of the Company.  For over 20 years, Mr. Divis has served in commercial and general management leadership roles with pharmaceutical companies such as Schering-Plough Corporation and Sanofi-Aventis.  This included direct responsibility for entire country operations in the UK and Ireland, extensive business development experience, and significant commercial leadership experience for large multi-national corporations.

Mr. Joseph Lehrer, lead director of the Company's Board, stated, "Since taking over as the Company's interim chief executive officer, Greg has demonstrated exceptional leadership skills and vast knowledge of the pharmaceutical industry.  Greg is guiding this organization through an important time in its recovery.  The Board, management and all of the Company's employees recognize Greg's leadership skills, and we look forward to working with Greg and the rest of the Company's management in achieving success for our employees, customers and shareholders."

A Focused Future for K-V in Branded Specialty Pharmaceuticals

In conjunction with the Company's securing its funding with affiliates of Centerbridge, K-V has made the strategic decision largely to tie its future to the development and commercialization of branded specialty pharmaceuticals.  The company is working with third party consultants and the U.S. Food & Drug Administration (FDA) to obtain approva
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... -- Varian Medical Systems (NYSE: VAR) today broke ground on new ... City manufacturing facility and allow for the consolidation ... to ultimately create 1,000 new full time jobs in ... " Utah is home to hardworking people ... be credited with Varian,s success in the manufacturing of our ...
(Date:8/27/2014)... Fla. , Aug. 27, 2014 By now, ... you,re likely not living on this planet. The awareness campaign ... consciousness and has helped to raise over $88.5 Million (and ... getting involved and some companies are starting to as well. ... Orlando, Florida , who actually works with ...
(Date:8/27/2014)... -- Hill-Rom Holdings, Inc. (NYSE: HRC ) invites ... Morgan Stanley Global Healthcare Conference on September 8, 2014, ... to listen to the live discussion via the internet ... at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP .  A recorded replay of the ... the live event and accessible at the links above ...
Breaking Medicine Technology:Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 4Acorn Stairlifts Gives a Lift to the ALS Ice Bucket Challenge 2
... Foundation Fighting Blindness ... Medicine, OWINGS MILLS, Md., April 27 Scientists employing ... nearly blind from,a condition known as Leber congenital amaurosis (LCA) ... clinical trial, which was,funded in part by the Foundation Fighting ...
... treatments A promising ... way Improved ability to select ... , At today,s sessions of this, the final day ... Study of the Liver (EASL), leading,hepatologists described several important advances ...
Cached Medicine Technology:Gene Therapy Provides Vision to People who Were Nearly Blind 2Molecular Discoveries Shed Light on Liver Cancer -- Hepatocellular Carcinoma (HCC) 2Molecular Discoveries Shed Light on Liver Cancer -- Hepatocellular Carcinoma (HCC) 3
(Date:8/27/2014)... play a key role in inflaming blood vessels and ... study at UCLA demonstrates that they may also contribute ... the small blood vessels in the lungs. , Using ... mimicking part of the main protein in high-density lipoprotein ... production of oxidized lipids in pulmonary hypertension. They also ...
(Date:8/27/2014)... Washington, New York (PRWEB) August 27, 2014 ... dedicated to protecting the rights of victims injured by ... new rules in place for discovery procedures, specifically Collection ... brought over C.R. Bard’s transvaginal mesh devices. (MDL No. ... Products Liability Litigation, the United States District Court, Southern ...
(Date:8/27/2014)... 27, 2014 (HealthDay News) -- There,s been controversy for ... women during their pregnancies might raise the odds of ... study involving more than 13,000 children finds no rise ... mothers used an antidepressant while pregnant, but some data ... these youngsters. The findings challenge prior research pointing ...
(Date:8/27/2014)... August 27, 2014 Picture, if you will, ... and Watson but more of a Mr. Inside, a Doc ... terms of personalities and world view. This Mr. Inside was ... Texas at Austin, and Mr. Outside was an Austin Police ... his new girlfriend, and a gaggle of teenagers embarked on ...
(Date:8/27/2014)... -- A new study finds that continuous positive airway ... sleep apnea. CPAP is widely used to treat ... which the airway relaxes and narrows during sleep, causing ... daytime drowsiness. CPAP keeps the airway open ... nose via a mask that is worn during sleep. ...
Breaking Medicine News(10 mins):Health News:Protein in 'good cholesterol' may be a key to treating pulmonary hypertension 2Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 2Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 3Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 4Health News:Do Antidepressants in Pregnancy Raise Risks for Mental Woes in Kids? 2Health News:Do Antidepressants in Pregnancy Raise Risks for Mental Woes in Kids? 3Health News:UW Rankin Self-Publishes Debut Novel, Sublimity: Perchance to Dream, A Speculative Science Mystery 2Health News:Sleep Apnea Treatment Helps Seniors, Study Finds 2
... are proposing a revolutionary approach to prevent the ... coronary arteries). ,More than 1.2 million angioplasties ... according to the American Heart Association. ... a tiny deflated balloon is inserted into clogged ...
... A finding by the advocacy group, Families USA, suggests that ... at least one parent employed full-time//. And in 25% of ... ,The group's executive director, Ron Pollack said "I ... who are very different from themselves. These are people who ...
... an agreement with Simcere Pharmaceutical Group of Nanjing, China ... of its flu drug Relenza in poor countries//. ... in China, Indonesia, Thailand, Vietnam and all least-developed countries, ... is doing everything we can to prepare for a ...
... Diego and Yale University have discovered that a natural ... crops by organic farmers to reduce insect damage, is ... ,Their discovery, detailed in this week’s early online ... Sciences, could pave the way for the development of ...
... intensive therapy with statin medications reduces death and ... attacks or other acute heart events//, according to ... cholesterol levels, have clearly been shown to benefit ... in the article. However, it is less clear ...
... No matter how many pelvic examinations a woman has, it’s ... place her feet up in metal stirrups//. Still, the stirrups ... vulvovaginal area and facilitate proper placement of exam instruments. According ... be an acceptable, less vexing alternative, reports the October 2006 ...
Cached Medicine News:Health News:Novel Technique Would Prevent Re-Clogged Arteries 2Health News:Bacterial Protein Shows Promise in Treating Intestinal Parasites 2Health News:Bacterial Protein Shows Promise in Treating Intestinal Parasites 3Health News:Early Statin Therapy for Patients Reduces Death, Cardiovascular Events 2
... Maximum Xtra, and Maximum ACT introducers ... and specialty hemostasis introducers in the ... premier hemostasis introducers for use in ... angiography, angioplasty, stenting, atherectomy, temporary pacing, ...
The intended use of the percutaneous PREFACE Guiding Sheath is for the introduction of intravascular electrophysiology catheters into any cardiac chamber....
... and Maximum ACT introducers represent the ... hemostasis introducers in the world. They ... introducers for use in interventional cardiology ... stenting, atherectomy, temporary pacing, endomyocardial biopsies, ...
Rapid Exchange Stent Delivery System with Hepacoat...
Medicine Products: